Companies /Healthcare
Adma Biologics Inc
NASDAQ: ADMA Biotechnology
$10.31
▲ $0.13 (+1.28%) today
Markets closed · 4:15am ET

ADMA Biologics (ADMA) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
33%
EPS beat rate
−3.66%
Avg. EPS surprise
Consecutive EPS misses
ADMA vs Market · 30-day return after each reportADMAS&P 500
−30%0%+30%−1.6%+6.7%Q1 25−2.2%+2.9%Q2 25+41.1%+1.9%Q3 25−39.7%−8.3%Q4 25−4.1%+0.8%Q1 26−5.2%−0.3%Q2 26
−30%0%+30%Q1 25Q3 25Q1 26
ADMA EPS Trend · estimate vs actualEstimateActual
$0.00$0.06$0.12$0.18$0.13$0.11Q1 25$0.14$0.14Q2 25$0.16$0.15Q3 25$0.20$0.20Q4 25$0.20$0.19Q1 26$0.16$0.16Q2 26
$0.00$0.06$0.12$0.18Q1 25Q3 25Q1 26
ADMA Revenue Trend · estimate vs actualEstimateActual
$0$40.0M$80.0M$120.0M$116.4M$114.8MQ1 25$121.8M$122.0MQ2 25$130.5M$134.2MQ3 25$139.8M$139.2MQ4 25$140.0M$114.5MQ1 26$125.4M$124.4MQ2 26
$0$40.0M$80.0M$120.0MQ1 25Q3 25Q1 26

How Often Does ADMA Biologics Beat Earnings Estimates?

ADMA Biologics beat EPS estimates in 2 of its last 6 reported quarters, and has missed 2 quarters in a row.

ADMA quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $0.16 est. $0.16 −2.02% $124.4M est. $125.4M −0.77%
Q1 2026 $0.19 est. $0.20 −5.00% $114.5M est. $140.0M −18.20%
Q4 2025 $0.20 est. $0.20 +0.00% $139.2M est. $139.8M −0.46%
Q3 2025 $0.15 est. $0.16 −3.23% $134.2M est. $130.5M +2.83%
Q2 2025 $0.14 est. $0.14 +3.70% $122.0M est. $121.8M +0.18%
Q1 2025 $0.11 est. $0.13 −15.38% $114.8M est. $116.4M −1.37%

Figures from SEC filings and company reports. Not investment advice.